Compare NIKHIL ADHESIVES with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NIKHIL ADHESIVES vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NIKHIL ADHESIVES TATVA CHINTAN PHARMA NIKHIL ADHESIVES/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 10.7 - - View Chart
P/BV x 5.0 31.4 15.8% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 NIKHIL ADHESIVES   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    NIKHIL ADHESIVES
Mar-21
TATVA CHINTAN PHARMA
Mar-21
NIKHIL ADHESIVES/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs484NA-   
Low Rs80NA-   
Sales per share (Unadj.) Rs1,069.7149.5 715.5%  
Earnings per share (Unadj.) Rs34.126.0 131.1%  
Cash flow per share (Unadj.) Rs41.629.4 141.8%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.5NM- 
Book value per share (Unadj.) Rs132.682.6 160.6%  
Shares outstanding (eoy) m4.5920.09 22.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.30-   
Avg P/E ratio x8.30-  
P/CF ratio (eoy) x6.80-  
Price / Book Value ratio x2.10-  
Dividend payout %4.40-   
Avg Mkt Cap Rs m1,2970-   
No. of employees `000NANA-   
Total wages/salary Rs m117241 48.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,9103,004 163.5%  
Other income Rs m359 4.9%   
Total revenues Rs m4,9133,063 160.4%   
Gross profit Rs m310659 47.0%  
Depreciation Rs m3567 51.4%   
Interest Rs m6744 149.9%   
Profit before tax Rs m212607 34.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5584 65.5%   
Profit after tax Rs m157523 30.0%  
Gross profit margin %6.322.0 28.8%  
Effective tax rate %26.113.9 187.7%   
Net profit margin %3.217.4 18.3%  
BALANCE SHEET DATA
Current assets Rs m2,3351,843 126.8%   
Current liabilities Rs m2,0281,180 171.8%   
Net working cap to sales %6.322.1 28.4%  
Current ratio x1.21.6 73.8%  
Inventory Days Days10 265.6%  
Debtors Days Days112,381,418110 101,912,900.2%  
Net fixed assets Rs m5571,306 42.7%   
Share capital Rs m46201 22.9%   
"Free" reserves Rs m5631,459 38.6%   
Net worth Rs m6091,660 36.7%   
Long term debt Rs m198268 74.0%   
Total assets Rs m2,8923,148 91.9%  
Interest coverage x4.214.6 28.5%   
Debt to equity ratio x0.30.2 201.6%  
Sales to assets ratio x1.71.0 177.9%   
Return on assets %7.718.0 42.8%  
Return on equity %25.731.5 81.6%  
Return on capital %34.533.8 102.1%  
Exports to sales %3.20-   
Imports to sales %56.80-   
Exports (fob) Rs m158NA-   
Imports (cif) Rs m2,787NA-   
Fx inflow Rs m1580-   
Fx outflow Rs m2,7870-   
Net fx Rs m-2,6290-   
CASH FLOW
From Operations Rs m229243 94.3%  
From Investments Rs m-74-210 35.3%  
From Financial Activity Rs m-157-88 178.6%  
Net Cashflow Rs m-2-55 3.8%  

Share Holding

Indian Promoters % 54.4 79.2 68.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 10.9 -  
FIIs % 0.0 3.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 45.6 20.8 218.7%  
Shareholders   4,844 89,438 5.4%  
Pledged promoter(s) holding % 22.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NIKHIL ADHESIVES With:   RESONANCE SPEC.  VADIVARHE SPECIALITY CHEMICALS  ARCHIT ORGANOSYS  CHEMFAB ALKALIS  VENLON POLY.  



Today's Market

Sensex Falls 1,100 Points from Day's High to End Marginally Lower; Metal & Energy Stocks Witness Selling(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices reversed course in intraday deals as global cues turned bearish.

Related Views on News

Tatva Chintan Makes Blockbuster Debut Doubling Investors Money (Views On News)

Jul 29, 2021

Tatva Chintan Pharma lists at 95% premium over issue price of Rs 1,083.

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NIKHIL ADHESIVES SHARE PRICE


Nov 30, 2021 (Close)

TRACK NIKHIL ADHESIVES

  • Track your investment in NIKHIL ADHESIVES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NIKHIL ADHESIVES

NIKHIL ADHESIVES 5-YR ANALYSIS

COMPARE NIKHIL ADHESIVES WITH

MARKET STATS